Literature DB >> 29167177

Smoothened signaling in the mouse osteoblastoid lineage is required for efficient B lymphopoiesis.

Wenyan Lu1, Dominic Dordai1, David Huso2, Stephen Desiderio1.   

Abstract

The stromal signals that promote B lymphopoiesis remain poorly understood. Hedgehog (Hh) signaling promotes B lymphopoiesis in a non-cell-autonomous fashion in vitro, and depletion of the Hh effector Smoothened (Smo) from stromal cells is associated with the loss of osteoblastoid markers. These observations suggested that Hh signaling in the osteoblastoid lineage promotes B lymphopoiesis in vivo. To test this, we employed a mouse model for conditional ablation of Smo in the osteoblastoid lineage. Depletion of Smo from osteoblastoid cells is associated with profound and selective reductions in the number and proportion of bone marrow B-lymphoid progenitors. Upon partial bone marrow ablation, mutant animals exhibit delayed repopulation of the B-lymphoid compartment after the early lymphoid progenitor stage. Primary osteoblasts from mutant mice are defective in supporting B lymphopoiesis in vitro, whereas hematopoietic progenitors from mutant mice exhibit normal differentiation. We conclude that efficient B lymphopoiesis in vivo is dependent on the maintenance of Hh signaling in the osteoblastoid lineage.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29167177      PMCID: PMC5774210          DOI: 10.1182/blood-2017-06-793539

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow.

Authors:  Hideya Igarashi; Sophia C Gregory; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

Review 2.  The Hedgehog response network: sensors, switches, and routers.

Authors:  Lawrence Lum; Philip A Beachy
Journal:  Science       Date:  2004-06-18       Impact factor: 47.728

3.  Characterization of B lymphopoiesis in mouse bone marrow and spleen.

Authors:  Richard R Hardy; Susan A Shinton
Journal:  Methods Mol Biol       Date:  2004

4.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

5.  Osteoblast isolation from murine calvaria and long bones.

Authors:  Astrid D Bakker; Jenneke Klein-Nulend
Journal:  Methods Mol Biol       Date:  2012

6.  A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates.

Authors:  Chauncey J Spooner; Jason X Cheng; Elisabet Pujadas; Peter Laslo; Harinder Singh
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

7.  The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms.

Authors:  Sarah L Siggins; Nhu-Y N Nguyen; Matthew P McCormack; Sumitha Vasudevan; Rehan Villani; Stephen M Jane; Brandon J Wainwright; David J Curtis
Journal:  Blood       Date:  2009-05-29       Impact factor: 22.113

8.  The Hedgehog receptor Patched controls lymphoid lineage commitment.

Authors:  Anja Uhmann; Kai Dittmann; Frauke Nitzki; Ralf Dressel; Milena Koleva; Anke Frommhold; Arne Zibat; Claudia Binder; Ibrahim Adham; Mirko Nitsche; Tanja Heller; Victor Armstrong; Walter Schulz-Schaeffer; Jürgen Wienands; Heidi Hahn
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

9.  Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration.

Authors:  Jennifer J Trowbridge; Matthew P Scott; Mickie Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

10.  Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice.

Authors:  Jianquan Chen; Yu Shi; Jenna Regan; Kannan Karuppaiah; David M Ornitz; Fanxin Long
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.